mitochondrial disease-arkiv - BioStock

Ellen Donnelly, CEO Abliva

Abliva’s CEO: We are the leading programme in mitochondrial disease

26 August, 2024

Ablivas CEO: "We remain on track for the interim analysis early in Q3"

Ablivas CEO: “We remain on track for the interim analysis early...

29 May, 2024

Abliva’s mission to become mitochondrial medicine powerhouse

Abliva’s mission to become mitochondrial medicine powerhouse

8 April, 2024

Abliva FALCON

Abliva reaches enrollment goal

21 December, 2023